Regulus Therapeutics
RGLS
#6960
Rank
ยฃ0.42 B
Marketcap
ยฃ6.14
Share price
0.00%
Change (1 day)
414.66%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2025 (TTM): -ยฃ36.82 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ34.75 Million a decrease over its 2023 earnings that were of -ยฃ22.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ36.82 Million5.97%
2024 -ยฃ34.75 Million56.97%
2023 -ยฃ22.14 Million6.51%
2022 -ยฃ20.78 Million2.53%
2021 -ยฃ20.27 Million93.59%
2020 -ยฃ10.47 Million-15.41%
2019 -ยฃ12.38 Million-64.46%
2018 -ยฃ34.82 Million-33.26%
2017 -ยฃ52.18 Million-13.98%
2016 -ยฃ60.66 Million44.77%
2015 -ยฃ41.9 Million-1.63%
2014 -ยฃ42.6 Million203.6%
2013 -ยฃ14.03 Million8.65%
2012 -ยฃ12.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
GlaxoSmithKline
GSK
ยฃ7.01 B-19,756.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
ยฃ6.84 B-19,287.12%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ1.43 B-4,114.42%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.84 B-27,699.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
ยฃ97.99 M-374.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-ยฃ81.99 Million 129.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.04 B-17,036.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.47 Million 148.06%๐Ÿ‡บ๐Ÿ‡ธ USA